1. Drug repurposing for cancer
   Juni Banerjee et al, 2024, Clinical Application of Repurposed Drugs CrossRef
2. The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin
   Ana Salomé Correia et al, 2023, Current Issues in Molecular Biology CrossRef
3. Depression, Inflammation, and the Moderating Role of Metformin: Results From the Midlife in the United States Study and Sacramento Area Latino Study on Aging
   Sumaiyah U. Syed et al, 2024, Psychosomatic Medicine CrossRef
4. A triple-drug combination induces apoptosis in cervical cancer-derived cell lines
   Izamary Delgado-Waldo et al, 2023, Frontiers in Oncology CrossRef
5. An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction
   Yanshijing Zhou et al, 2024, Pharmacogenomics and Personalized Medicine CrossRef
6. Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissues
   Giorgia Ailuno et al, 2023, Journal of Pharmaceutical and Biomedical Analysis CrossRef
7. Role and regulation of FOXO3a: new insights into breast cancer therapy
   Wenqiu Mei et al, 2024, Frontiers in Pharmacology CrossRef
8. A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases
   Miran Rada et al, 2023, Biomedicines CrossRef
9. Diabetes and Cancer: A Twisted Bond
   Mihai Cosmin Stan et al, 2024, Oncology Reviews CrossRef
10. Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa
    Andreea Petrasca et al, 2023, British Journal of Dermatology CrossRef
11. Countermeasure development against space radiation-induced gastrointestinal carcinogenesis: Current and future perspectives
    Shubhankar Suman et al, 2022, Life Sciences in Space Research CrossRef
12. Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
    Devalingam Mahalingam et al, 2023, Oncotarget CrossRef
13. Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway
    Jui-Ling Hsu et al, 2024, Oncology Letters CrossRef
14. Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus
    Julianah Ore Abiola et al, 2024, Pharmaceuticals CrossRef
15. The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer
    Hans Raskov et al, 2023, Cancers CrossRef
16. Metformin as a booster of cancer immunotherapy
    Jutatip Panaampon et al, 2023, International Immunopharmacology CrossRef
17. Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor–adipocyte interaction indicating an altered immune response
    Bianca Grosser et al, 2024, Gastric Cancer CrossRef
18. Metformin increases 3-hydroxy medium chain fatty acids in patients with type 2 diabetes: a cross-sectional pharmacometabolomic study
    Khaled Naja et al, 2024, Frontiers in Endocrinology CrossRef
19. Metformin: A Small Molecule with Multi-Targets and Diverse Therapeutic Applications
    Farid A. Badria et al, 2023, Metformin - A Prospective Alternative for the Treatment of Chronic Diseases CrossRef